Literature DB >> 25168394

Brain histopathology in three cases of Susac's syndrome: implications for lesion pathogenesis and treatment.

Todd A Hardy1, Billy O'Brien2, Natasha Gerbis3, Michael H Barnett4, Stephen W Reddel5, Janice Brewer6, Geoffrey K Herkes3, Paul Silberstein3, Roger J Garsia7, John D G Watson8, Ruta Gupta9, John D E Parratt10, Michael E Buckland11.   

Abstract

Entities:  

Keywords:  Histopathology; Immunology; Neuroimmunology; Neuropathology; Vasculitis

Mesh：

Year:  2014        PMID： 25168394     DOI： 10.1136/jnnp-2014-308240

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  8 in total

1.  Treatment of Susac Syndrome.

Authors:  Ivana Vodopivec; Sashank Prasad
Journal:  Curr Treat Options Neurol       Date:  2016-01       Impact factor: 3.598

Review 2.  Distinguishing Susac's syndrome from multiple sclerosis.

Authors:  Katherine A Buzzard; Stephen W Reddel; Con Yiannikas; D Sean Riminton; Michael H Barnett; Todd A Hardy
Journal:  J Neurol       Date:  2014-12-30       Impact factor: 4.849

3.  [Susac syndrome-interdisciplinary tracking of the chameleon: two different case reports].

Authors:  D Schelenz; I Kleffner; N Tsiampalis; H Burkhard Dick; J Rehrmann
Journal:  Ophthalmologe       Date:  2020-04       Impact factor: 1.059

4.  Diagnosis and Prediction of Relapses in Susac Syndrome: A New Use for MR Postcontrast FLAIR Leptomeningeal Enhancement.

Authors:  S Coulette; A Lecler; E Saragoussi; K Zuber; J Savatovsky; R Deschamps; O Gout; C Sabben; J Aboab; A Affortit; F Charbonneau; M Obadia
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-27       Impact factor: 3.825

Review 5.  Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases.

Authors:  Heinz Wiendl; Catharina C Gross; Jan Bauer; Doron Merkler; Alexandre Prat; Roland Liblau
Journal:  Nat Rev Neurol       Date:  2021-05-28       Impact factor: 42.937

6.  CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome.

Authors:  Catharina C Gross; Céline Meyer; Urvashi Bhatia; Lidia Yshii; Ilka Kleffner; Jan Bauer; Anna R Tröscher; Andreas Schulte-Mecklenbeck; Sebastian Herich; Tilman Schneider-Hohendorf; Henrike Plate; Tanja Kuhlmann; Markus Schwaninger; Wolfgang Brück; Marc Pawlitzki; David-Axel Laplaud; Delphine Loussouarn; John Parratt; Michael Barnett; Michael E Buckland; Todd A Hardy; Stephen W Reddel; Marius Ringelstein; Jan Dörr; Brigitte Wildemann; Markus Kraemer; Hans Lassmann; Romana Höftberger; Eduardo Beltrán; Klaus Dornmair; Nicholas Schwab; Luisa Klotz; Sven G Meuth; Guillaume Martin-Blondel; Heinz Wiendl; Roland Liblau
Journal:  Nat Commun       Date:  2019-12-18       Impact factor: 14.919

7.  Diagnosis, differential diagnosis and misdiagnosis of Susac syndrome.

Authors:  James D Triplett; Jessica Qiu; Billy O'Brien; Sumana Gopinath; Benjamin Trewin; Penelope J Spring; Mohamed Shaffi; Jerome Ip; Fiona Chan; Luke Chen; Ian Wilson; Claire Muller; Heidi N Beadnall; Mike Boggild; Anneke Van der Walt; Richard Roxburgh; Nabil Seery; Tomas Kalincik; Michael H Barnett; John D E Parratt; Stephen W Reddel; Benjamin Tsang; Todd A Hardy
Journal:  Eur J Neurol       Date:  2022-03-25       Impact factor: 6.288

8.  Incomplete Susac syndrome exacerbated after natalizumab.

Authors:  Lana Zhovtis Ryerson; Ilya Kister; Matija Snuderl; Cynthia Magro; Bibiana Bielekova
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-09-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.